Evidence map›Paper›PMID 28099507›Full record

ArticlePloS one2017

Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the HdhQ150/Q150 Mouse Model of Huntington's Disease.

Ivan Rattray, Edward J Smith, William R Crum, Thomas A Walker, Richard Gale, Gillian P Bates, Michel Modo

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Pathomechanisms of behavioral abnormalities in Huntington disease: an update.Journal of neural transmission (Vienna, Austria : 1996) · 2024
    Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Glutamatergic Synapse Dysfunction inFrontiers in molecular neuroscience · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington's Disease: Preclinical Evidence with the p75Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ivan RattrayKing's College London, Institute of Psychiatry, Department of Neuroscience, London, United Kingdom.
Edward J SmithKing's College London, Institute of Psychiatry, Department of Neuroscience, London, United Kingdom.
William R CrumKing's College London, Department of Neuroimaging, Institute of Psychiatry London, United Kingdom.
Thomas A WalkerKing's College London School of Medicine, Department of Medical and Molecular Genetics, Guy's Hospital, London, United Kingdom.
Richard GaleKing's College London School of Medicine, Department of Medical and Molecular Genetics, Guy's Hospital, London, United Kingdom.
Gillian P BatesKing's College London School of Medicine, Department of Medical and Molecular Genetics, Guy's Hospital, London, United Kingdom.
Michel ModoKing's College London, Institute of Psychiatry, Department of Neuroscience, London, United Kingdom.ORCID http://orcid.org/0000-0003-4436-735X

Funding

Medical Research Council G0800846
6 · The paper itself

Abstract

A variety of mouse models have been developed that express mutant huntingtin (mHTT) leading to aggregates and inclusions that model the molecular pathology observed in Huntington's disease. Here we show that although homozygous HdhQ150 knock-in mice developed motor impairments (rotarod, locomotor activity, grip strength) by 36 weeks of age, cognitive dysfunction (swimming T maze, fear conditioning, odor discrimination, social interaction) was not evident by 94 weeks. Concomitant to behavioral assessments, T2-weighted MRI volume measurements indicated a slower striatal growth with a significant difference between wild type (WT) and HdhQ150 mice being present even at 15 weeks. Indeed, MRI indicated significant volumetric changes prior to the emergence of the "clinical horizon" of motor impairments at 36 weeks of age. A striatal decrease of 27% was observed over 94 weeks with cortex (12%) and hippocampus (21%) also indicating significant atrophy. A hypothesis-free analysis using tensor-based morphometry highlighted further regions undergoing atrophy by contrasting brain growth and regional neurodegeneration. Histology revealed the widespread presence of mHTT aggregates and cellular inclusions. However, there was little evidence of correlations between these outcome measures, potentially indicating that other factors are important in the causal cascade linking the molecular pathology to the emergence of behavioral impairments. In conclusion, the HdhQ150 mouse model replicates many aspects of the human condition, including an extended pre-manifest period prior to the emergence of motor impairments.

Indexed as

AnimalsCerebral CortexCognitive DysfunctionCorpus StriatumDisease Models, AnimalFemaleGene Knock-In TechniquesHippocampusHuntingtin ProteinHuntington DiseaseMagnetic Resonance ImagingMaleMaze LearningMiceMice, Inbred C57BLMice, Inbred CBAHtt protein, mouseHuntingtin Protein

Identifiers

PMID28099507
PMCPMC5242535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.